EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection

Clinical trial NCT00105183 · COMPLETED

Trial details

NCT number: NCT00105183
Sponsor: Neovii Biotech
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Idiopathic Pulmonary Fibrosis Cystic Fibrosis Bronchiectasis Pulmonary Vascular Disease

Start date: 2005-01-01
Primary completion: 2010-01-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.